Chemotherapy Biotherapy Certification ONS Practice Testq

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ONS Chemotherapy Biotherapy Certification Exam. Leverage flashcards and multiple choice questions, complete with hints and explanations. Equip yourself for exam success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What effect do hematopoietic growth factors have on neutrophil recovery?

Increase the duration of neutropenia
Reduce the time for neutrophil recovery
Maximize the risk of infections
Eliminate the need for blood transfusions

The correct answer is: Reduce the time for neutrophil recovery

Hematopoietic growth factors are biological agents that stimulate the production of hematopoietic progenitor cells, particularly in the bone marrow. When it comes to neutrophils, these growth factors, such as Granulocyte Colony-Stimulating Factor (G-CSF), play a pivotal role in accelerating the recovery of neutrophil counts after chemotherapy or bone marrow suppression. By enhancing the proliferation and differentiation of granulocyte precursors, these factors effectively shorten the duration of neutropenia, which is a common side effect of many chemotherapy regimens. As a result, patients experience a quicker return to a normal or near-normal level of neutrophils, reducing the risk of infections that often accompany low neutrophil counts. Sustained neutropenia can leave patients vulnerable to infections, and recovery enhancements associated with growth factors are particularly significant in the management of these patients. Thus, the primary effect of hematopoietic growth factors is to reduce the time required for neutrophil recovery, allowing for better management of side effects and improved patient outcomes during chemotherapy treatments.